Ablynx

@AblynxABLX

Ablynx is a biopharmaceutical company engaged in the discovery and development of Nanobodies® for a range of serious human diseases.

Ghent/Zwijnaarde, Belgium
ablynx.com
Clárú: Bealtaine 2012
5 Phictiúr nó físeán Pictiúir agus físeáin

Tweetanna

You blocked @AblynxABLX

Are you sure you want to view these Tweets? Viewing Tweets won't unblock @AblynxABLX

  1. Rinne Atweetáil
    26 Iúil

    FDA designates top nanobody caplacizumab fast track designation: 6-10 months faster approval

    3 atweetáil 4 chroí
  2. Rinne Atweetáil
    20 Iúil

    2.4bn "bioeuro": Belgian Nanobody delights now also tasteful in France

    2 atweetáil 7 gcroí
  3. 20 Iúil

    and Sanofi to develop up to 8 Nanobody®-based therapeutics focused on immuno-inflammatory diseases

    1 fhreagra amháin 9 n-atweetáil 14 croí
  4. 27 Meith

    achieves second milestone in immuno-oncology collaboration with Merck & Co., Inc.

    7 n-atweetáil 16 croí
  5. 26 Meith

    initiates a single and multiple dose Phase I study of caplacizumab in healthy Japanese subjects

    4 atweetáil 6 chroí
  6. 29 Beal

    launches , a new website dedicated to Thrombotic Thrombocytopenic Purpura (TTP)

    10 n-atweetáil 9 gcroí
  7. 22 Beal

    receives €15M milestone from Merck KGaA for novel Nanobody in osteoarthritis

    10 n-atweetáil 12 croí
  8. 18 Beal

    Meet our experts and recruiters (booth 99) @

    2 chroí
  9. 11 Beal

    Ablynx zit op schema via

    4 atweetáil 6 chroí
  10. 11 Beal

    Q1 2017 "Positive start of the year; good progress in multiple programmes; strong cash position"

    6 atweetáil 4 chroí
  11. 10 Beal

    Publication in Journal of Thrombosis and Haemostasis "Caplacizumab reduces major thromboembolic events"

    7 n-atweetáil 7 gcroí
  12. 2 Beal

    successfully completes patient recruitment in its Phase III Hercules study of caplacizumab

    2 atweetáil 6 chroí
  13. 7 Aib

    Annual Report 2016 is available online - view via

    1 atweetáil amháin 4 chroí
  14. 7 Aib

    - Adrianus van Herk (aandeelhouder Ablynx): 'België en Nederland zijn wereldtop' via @trends

    1 atweetáil amháin 4 chroí
  15. Rinne Atweetáil
    6 Márta

    Compelling data for developed psoriasis nanobody in collaboration

    3 atweetáil 2 chroí
  16. Rinne Atweetáil
    28 Feabh

    Good morning to those waking up in Europe, Africa and the Middle East! Share with us what you have planned for today!

    15 freagra 51 d’atweetálacha 103 croí
  17. Rinne Atweetáil
    24 Feabh

    you will find out that is dedicated to creating new medicines which will make a real difference to society!

    1 atweetáil amháin 1 chroí
  18. 23 Feabh

    FYR 2016: significant progress in R&D pipeline; strong cash position; major catalysts in 2017.

    4 atweetáil 3 chroí
  19. 9 Feabh

    will present additional data from the Phase IIb RA combination study of vobarilizumab at the Annual CRA Meeting

    2 atweetáil 2 chroí
  20. 6 Feabh

    Ablynx files caplacizumab for ultra rare blood disorder
    6 atweetáil 9 gcroí

@AblynxABLX hasn't Tweeted yet.

Tá moill ar an lódáil, is cosúil.

Tá Twitter ag cur thar maoil le gníomhaíocht nó tá fadhb eile ann. Bain triail eile as nó tabhair cuairt ar Stádas Twitter chun tuilleadh eolais a fháil.

    Seans, leis, go dtaitneodh seo leat

    ·